Table 3.
Associations between risk factors and mortality among haemodialysis patients by multiple logistic regression analysis.
| Factors | Univariate |
Multivariate |
||
|---|---|---|---|---|
| OR (95% CI) | P | Adjusted OR (95% CI) | P | |
| Omicron variant infection | ||||
| Yes vs. no | 2.70 (1.29–5.65) | 0.0084 | 2.64 (1.25–5.58) | 0.0109 |
| Age | ||||
| ≥65 years vs. <65 years | 2.33 (1.08–5.03) | 0.0311 | 2.34 (1.08–5.07) | 0.0312 |
| Sex | ||||
| Female vs. male | 1.06 (0.48–2.34) | 0.8854 | 0.97 (0.43–2.19) | 0.9415 |
| Diabetes | ||||
| Yes vs. no | 1.42 (0.65–2.99) | 0.3791 | 1.50 (0.68–3.31) | 0.3151 |
| Dialysis duration | ||||
| ≥48 months vs. <48 months | 1.12 (1.04–1.21) | 0.0027 | 1.15 (1.06–1.25) | 0.0008 |
| Vascular access approach | ||||
| CVC vs. internal fistula | 2.89 (1.25–6.68) | 0.0131 | 2.24 (0.93–5.40) | 0.0722 |
| *Nucleic acid quantification | ||||
| CT values (ORF) | ||||
| ≥21 vs. <21 | 2.54 (0.39–9.62) | 0.3259 | 2.65 (0.40–16.54) | 0.3259 |
| CT values (N gene) | ||||
| ≥21 vs. <21 | 1.90 (0.29–12.45) | 0.5033 | 2.06 (0.31–13.69) | 0.4545 |
| *Days to viral clearance | ||||
| ≥11 days vs. <11 days | 6.01 (2.33–15.50) | 0.0002 | 5.78 (2.15–15.54) | 0.0005 |
CVC: central venous catheter.
CT: cycle threshold.
OR: odds ratio.
*The analysis data included only COVID-19 patients.